As the first female Superintendent Pharmacist in LloydsPharmacy’s history, Victoria Steele will replace outgoing Superintendent Steve Howard, who retires from the business at the end of this year after 35 years’ service.
Victoria qualified as a pharmacist in 2000 and joined McKesson UK in 2011. Currently Deputy Superintendent for LloydsPharmacy and Head of Clinical Governance and Professional Standards, Victoria provides expert guidance on clinical and patient safety issues.
McKesson UK CEO Toby Anderson said: “I’m delighted to congratulate Victoria on her new appointment, both for the opportunity it presents for her as an individual, and as the first female Superintendent Pharmacist in LloydsPharmacy’s history. Victoria has played an integral role in the business’ response to the COVID-19 pandemic with a focus on getting medicines to patients safely and the health and welfare of our colleagues. Her knowledge, experience and enthusiasm for the profession will be incredibly valuable in such a pivotal year for pharmacy.”
In addition to her work at McKesson UK, Victoria is Vice Chair of the Community Pharmacy Patient Safety Group, and of the Professional Practise Group for The Company Chemist’s Association (CCA). She also has a strong relationship with the General Pharmaceutical Council (GPhC) and has worked closely with them on their Fitness to Practise agenda.
Victoria is especially proud of SaferCare, the LloydsPharmacy patient safety programme that she introduced in 2013. As part of her new role, she will continue to lead this as well as the company’s Pharmacy Listening Groups, providing professional guidance to the wider community pharmacy network.
Victoria Steele commented: “I am delighted to accept this new challenge and carry on the great work that Steve has achieved. I hope to use my passion for patient safety, professionalism and safeguarding to continue providing patients with the best possible care as well as encouraging good pharmacists to become great pharmacists. I look forward to helping guide the business through this challenging time with our patients’ interests at the core of everything we do.”